Therefore, it may be inferred that CALM3 inhibits tumor immunity by inhibiting CD8+T cells through glucose metabolism, thus leading to poor prognosis of HCC with high expression of CALM3+CD8+ T cells-C1 cell clusters. This evidence concerns the gene CALM3 and hepatocellular carcinoma.